Cholera News and Research

Latest Cholera News and Research

Researchers unveil mechanism of cholera bacteria to create cell energy

Researchers have found that an enzyme in the bacteria that causes cholera uses a previously unknown mechanism in providing the bacteria with energy. Because the enzyme is not found in most other organisms, including humans, the finding offers insights into how drugs might be created to kill the bacteria without harming humans.

29 Jul 2010

Neu5Gc in drugs provokes strong immune response

Researchers at the University of California, San Diego School of Medicine have discovered that a kind of sugar molecule common to chimpanzees, gorillas and other mammals but not found in humans provokes a strong immune response in some people, likely worsening conditions in which chronic inflammation is a major issue.

26 Jul 2010

Biomagnetics Diagnostics reports positive test results of unique PVA film formulation

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the results of recent testing of the unique PVA film formulation produced by Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. Earlier this week, Biomagnetics announced its intent to acquire Lanzhou as the first of several planned acquisitions to be done at a $1.00 share price valuation for Biomagnetics Diagnostics' common shares.

15 Jul 2010

Biomagnetics signs LOI to acquire Lanzhou Sanhuan New Technology Development

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.

12 Jul 2010

Biomagnetics, LANL collaborate to develop device for tuberculosis diagnosis

Biomagnetics Diagnostics Corp., a developer of revolutionary technology for diagnostic systems for HIV, hepatitis, tuberculosis and malaria detection, today announced the signing of an agreement with Los Alamos National Security, LLC where Los Alamos National Laboratory's scientific and engineering staffs will attempt to identify new potential human tuberculosis biomarkers and will develop a validated assay to detect human tuberculosis using a currently known biomarker to be used in combination with the waveguide-based optical biosensor platform.

9 Jul 2010

Biomagnetics Diagnostics signs new CRADA with Los Alamos National Security

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced the signing of a new Cooperative Research and Development Agreement with Los Alamos National Security, LLC for the development of a waveguide-based integrated optical biosensor platform for the detection of disease causing pathogens.

7 Jul 2010

Researchers study mechanism of human brain

Because of its intricate organization, figuring out the wiring diagram that explains how the billions of neurons in the brain are connected, and determining how they work together, remains a formidable task.

29 Jun 2010

Increased mortality rates in Bangladesh is associated with arsenic exposure, study finds

Between 33 and 77 million people in Bangladesh have been exposed to arsenic in the drinking water-a catastrophe that the World Health Organization has called "the largest mass poisoning in history." A new study published in the current issue of the medical journal The Lancet provides the most complete and detailed picture to date of the high mortality rates associated with this exposure, which began with the widespread installation of tube wells throughout the country 30 years ago-a measure intended to control water-bourne diseases.

24 Jun 2010

Financial Times examines how GAVI's $2.6B shortfall might affect new vaccine programs in developing countries

GAVI Alliance's plan to introduce new vaccine projects in the developing world "is under threat amid the international economic downturn," the Financial Times reports. "Subsidies to extend the use of vaccines against rubella, HPV to tackle cervical cancer, cholera and Japanese encephalitis in the developing world are among those likely to be cancelled or delayed," according to GAVI's CEO Julian Lob-Levyt, the newspaper writes.

17 Jun 2010

Helicobacter pylori's helical shape helps it colonize the stomach

The bacterium Helicobacter pylori, which lives in the human stomach and is associated with ulcers and gastric cancer, is shaped like a corkscrew, or helix. For years researchers have hypothesized that the bacterium's twisty shape is what enables it to survive - and thrive - within the stomach's acid-drenched environment, but until now they have had no proof.

28 May 2010

Biomagnetics Diagnostics presents new series of videos on world's first handheld Integrated Optical Biosensor

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced the availability of a new series of video taped interviews of CEO, Clayton Hardman where he presents the world's first handheld Integrated Optical Biosensor (IOBS), which was recently licensed under an agreement with Los Alamos National Security LLC.

25 May 2010

Using sari cloth to filter water protects household from cholera: Study

A five-year follow up study in Bangladesh finds that women are literally wearing the answer to better health for themselves, their families and even their neighbors. Using the simple sari to filter household water protects not only the household from cholera, but reduces the incidence of disease in neighboring households that do not filter.

20 May 2010

VBI researchers establish new tree of life for gamma-proteobacteria

A new "tree of life" has been constructed by researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech for the gamma-proteobacteria, a large group of medically and scientifically important bacteria that includes Escherichia coli, Salmonella typhimurium, and other disease-causing organisms.

18 May 2010

Leaving food out in the sun can put you at risk for food-borne illness

Leaving food out in the sun too long can put a damper on your summer picnic.

14 May 2010

Scientists develop dry, inhalable measles vaccine, will begin testing in India this summer

CBSNews.com reports on the development of a dry, inhalable measles vaccine by researchers at the University of Colorado-Boulder (CU-Boulder), who hope that their work will "help pave the way for the inexpensive treatment of a range of other illnesses" (Cooper, 5/5).

10 May 2010

MIT, South Africa announce plans to join patent pool for 'neglected diseases'

Massachusetts Institute of Technology (MIT) and South Africa's Technology Innovation Agency (TIA) will join the Pool for Open Innovation against Neglected Tropical Diseases, Science|Business reports.

10 May 2010

Napo Pharmaceuticals announces formation of Finder's Agreement with Luye Pharma Group

Napo Pharmaceuticals, Inc., which focuses on the development and commercialization of proprietary pharmaceuticals for the treatment of diarrheal diseases in the global marketplace in collaboration with local partners, is pleased to announce the formation of a Finder's Agreement with its licensee for crofelemer in China, Luye Pharma Group Ltd. (formerly Asiapharm).

26 Apr 2010

Biomagnetics Diagnostics receives commitment for clinical validation testing in India for malaria, TB diagnosis

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced it has received important commitments from two leading research laboratories in India for clinical validation testing for malaria and tuberculosis (TB) detection and diagnosis.

21 Apr 2010

House markup of supplemental spending bill that includes Haiti relief delayed one week

A supplemental spending bill that is expected to include earthquake relief aid for Haiti will be considered by the full House Defense Appropriations Subcommittee during the week of April 26 and will not be written this week as several aides and members had anticipated, C.W. Bill Young, the committee's ranking Republican from Florida, said, CQ Today reports.

20 Apr 2010

WHO Director-General turns attention to conditions in slums to mark World Health Day

WHO Director-General Margaret Chan said addressing living conditions in the world's slums is important to improving urban health - the focus of World Health Day on Wednesday, Agence France-Presse reports.

9 Apr 2010

Cholera News and Research

Latest Cholera News and Research

Researchers unveil mechanism of cholera bacteria to create cell energy

Neu5Gc in drugs provokes strong immune response

Biomagnetics Diagnostics reports positive test results of unique PVA film formulation

Biomagnetics signs LOI to acquire Lanzhou Sanhuan New Technology Development

Biomagnetics, LANL collaborate to develop device for tuberculosis diagnosis

Biomagnetics Diagnostics signs new CRADA with Los Alamos National Security

Researchers study mechanism of human brain

Increased mortality rates in Bangladesh is associated with arsenic exposure, study finds

Financial Times examines how GAVI's $2.6B shortfall might affect new vaccine programs in developing countries

Helicobacter pylori's helical shape helps it colonize the stomach

Biomagnetics Diagnostics presents new series of videos on world's first handheld Integrated Optical Biosensor

Using sari cloth to filter water protects household from cholera: Study

VBI researchers establish new tree of life for gamma-proteobacteria

Leaving food out in the sun can put you at risk for food-borne illness

Scientists develop dry, inhalable measles vaccine, will begin testing in India this summer

MIT, South Africa announce plans to join patent pool for 'neglected diseases'

Napo Pharmaceuticals announces formation of Finder's Agreement with Luye Pharma Group

Biomagnetics Diagnostics receives commitment for clinical validation testing in India for malaria, TB diagnosis

House markup of supplemental spending bill that includes Haiti relief delayed one week

WHO Director-General turns attention to conditions in slums to mark World Health Day

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Cholera News and Research

Latest Cholera News and Research

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in